Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT01644461
Other study ID # KRPL/HPL-FR/11-12/002B
Secondary ID
Status Active, not recruiting
Phase Phase 1/Phase 2
First received July 17, 2012
Last updated July 24, 2012
Start date April 2012
Est. completion date November 2012

Study information

Verified date July 2012
Source Kasiak Research Pvt. Ltd.
Contact n/a
Is FDA regulated No
Health authority India: Institutional Review Board
Study type Interventional

Clinical Trial Summary

This is a multicentre, open label, pilot study to evaluate safety and efficacy of Autologous Human Platelet Lysate (HPL) in subjects with Facial Wrinkles (Nasolabial Folds). The study is being conducted at 2 centers in India. The primary endpoints are Improvement in Wrinkle Severity Rating Scale ( WSRS ) as per ATLAS photographic grading at rest and on full smile and Global Aesthetic Improvement Scale (GAIS). The secondary endpoints are improvement in photographic assessment, Physician's assessment scores, Patient's assessment scores form enrollment to end of study.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 20
Est. completion date November 2012
Est. primary completion date October 2012
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

- Subjects (male and female), aged 18 to 40 years (both inclusive).

- Subjects willing to refrain from any other treatment for Nasolabial Folds.

- Subjects who are willing to give informed consent and adhere to the study protocol.

Exclusion Criteria:

- Subjects receiving any aesthetic facial therapy 6 months prior to enrolment e.g. Botox, Fillers etc

- Subjects with history of Connective tissue disease

- Subjects with autoimmune diseases

- Subjects unwilling to or unable to comply with the study protocol.

- Subjects taking concomitant therapy that might interfere with the study results in the investigator's opinion or participating in another trial in the past 30days

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Facial Wrinkles (Nasolabial Folds)
  • Facies

Intervention

Other:
Autologous Human Platelet Lysate
All subjects will receive a single injection of Autologous Human Platelet Lysate in the nasolabial region

Locations

Country Name City State
India Kasiak Research Pvt Ltd Thane Maharashtra

Sponsors (1)

Lead Sponsor Collaborator
Kasiak Research Pvt. Ltd.

Country where clinical trial is conducted

India, 

Outcome

Type Measure Description Time frame Safety issue
Other Photographic assessments Day 0, Month 1, Month 2, End of study - Month 3 No
Other Physician's assessment scores End of Study - 3 months No
Other Patient's assessment scores End of Study - 3 months No
Primary Wrinkle Severity Rating Scale as per ATLAS photographic grading at rest & on full smile Day 0, End of Study - 3 months No
Secondary Global Aesthetic Improvement Scale Day 0, End of study - Month 3 No